Acquisition by Carlson Peter M of 35211 shares of MIMEDX GROUP subject to Rule 16b-3
| By Carlson Peter M | Macroaxis Story |
Filed transaction by Mimedx Group Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Transaction by Carlson Peter M
How important is MiMedx's Liquidity
MiMedx financial leverage refers to using borrowed capital as a funding source to finance MiMedx Group ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. MiMedx financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to MiMedx's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of MiMedx's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between MiMedx's total debt and its cash.
MiMedx Gross Profit
MiMedx Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing MiMedx previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show MiMedx Gross Profit growth over the last 10 years. Please check MiMedx's gross profit and other fundamental indicators for more details.
Details
MIMEDX insider trading alert for grant of common stock by Carlson Peter M, Chief Financial Officer, on 7th of July 2020. This event was filed by Mimedx Group Inc with SEC on 2020-07-07. Statement of changes in beneficial ownership - SEC Form 4
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio Architect